Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Socie, Gerard [1 ]
Varoqueaux, Nathalie [2 ]
de Latour, Regis Peffault [1 ]
机构：
[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France
[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France
来源：
M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;
D O I：
10.1051/medsci/200925121126
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.
引用
收藏
页码：1126 / 1129
页数：4
相关论文
共 50 条
  • [21] Evaluation of the use of eculizumab for treatment of paroxysmal nocturnal hemoglobinuria
    Maria de Andres, Ana
    Sola, Nuria
    Creus, Natalia
    Codina, Carles
    Ribas, Josep
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 299 - 300
  • [22] The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
    Yenerel, Mustafa Nuri
    Erdem, Simge
    Mastanzade, Metban
    Nalcaci, Meliha
    BLOOD, 2018, 132
  • [23] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [24] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
  • [25] POSITIVE OUTCOMES OF THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH ECULIZUMAB THERAPY
    Villegas, A.
    Urbano, A.
    Cuevas, M.
    Roncero, M.
    Ruiz, B.
    Cordoba, R.
    Fernandez, F.
    Toscano, R.
    Gaya, A.
    Bermejo, A.
    Mardones, L.
    Loureiro, C.
    Moreno, D.
    Alcala, A.
    De La Iglesia, S.
    Calvillo, M.
    Menayo, M.
    Gonzalez, A.
    Arrizabalaga, B.
    HAEMATOLOGICA, 2013, 98 : 579 - 579
  • [26] EFFICACY AND SAFETY OF ECULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Reiss, U.
    Schwartz, J.
    Puthenveetil, G.
    Ogawa, M.
    Ware, R.
    HAEMATOLOGICA, 2012, 97 : 370 - 371
  • [27] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
    Fassett, Michael J.
    Lopez, Adrian L. Hernandez
    CASE REPORTS IN WOMENS HEALTH, 2021, 30
  • [28] Efficacy and Safety of Eculizumab in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria
    Reiss, Ulrike M.
    Schwartz, Jeffrey
    Sakamoto, Kathleen M.
    Puthenveetil, Geetha
    Ogawa, Masayo
    Bedrosian, Camille L.
    Ware, Russell E.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (09) : 1544 - 1550
  • [29] Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatment
    Arcavi, Miriam
    Ceballo, Fernanda
    Caracciolo, Maria Beatriz
    Lazarowski, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 335 - 340
  • [30] EXTRAVASCULAR HEMOLYSIS DURING TREATMENT WITH ECULIZUMAB FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Graciaa, Sara
    Chonat, Satheesh
    PEDIATRIC BLOOD & CANCER, 2019, 66
12345